The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies.EBI
Institute of Chemical Technology
Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.EBI
Institute of Chemical Technology
Novel 3-O-acyl mesquitol analogues as free-radical scavengers and enzyme inhibitors: synthesis, biological evaluation and structure-activity relationship.EBI
Institute of Chemical Technology
Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands.EBI
Institute of Chemical Technology
10H-Phenothiazines: a new class of enzyme inhibitors for inflammatory diseases.EBI
Institute of Chemical Technology
Free-radical-scavenging and xanthine oxidase inhibitory constituents from Stereospermum personatum.EBI
Institute of Chemical Technology
Oxadiazole scaffolds in anti-tuberculosis drug discovery.EBI
Institute of Chemical Technology
Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.EBI
Institute of Chemical Technology
CompoundsBDB
Boehringer Ingelheim International